In one paragraphArticle in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Lachlan L WalkerInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Nguyen Thi Khanh NhuInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-0158-850X Zheng Jie LianInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Kate M PetersInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Mercedes MonteleoneInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
James P R ConnollyNewcastle University Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Mark J WalkerInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-7423-2769 Brian M FordeInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-2264-4785 Kate SchroderInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0001-9261-3805 Matthew J SweetInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-0406-8139 Minh-Duy PhanInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0002-3426-1044 Mark A SchembriInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0003-4863-9260 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
AcetyltransferasesBacterial CapsulesEscherichia coli ProteinsNeutrophilsUropathogenic Escherichia coliAcetylationAnimalsAntigens, BacterialDisease Models, AnimalEscherichia coli InfectionsFemaleHumansMicePolysaccharides, BacterialUrinary Tract InfectionsAcetyltransferasesAntigens, Bacterialcapsular polysaccharide K1Escherichia coli ProteinsPolysaccharides, Bacterialbacterial pathogenesisbacterial virulencecapsulephase variationurinary tract infectionuropathogenic Escherichia coli
Identifiers
PMID41665341
PMCPMC13001214
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390